Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
Inside Drug Pricing: IRA Suits Dismissed Back-To-Back By Two Appeals Courts
Patients for Affordable Drugs and other advocates for federal drug pricing reform are pleased with the back-to-back appellate decisions. The BI ruling further emphasizes that pharmaceutical companies cannot claim constitutional violations because they are opposed to the terms of doing business with the government, the advocates said. “It’s the U.S. versus Pharma, and today’s decision […]
News and Reports
The Hill: Appeals court upholds dismissal of US Chamber challenge to Medicare negotiation
The advocacy group Patients For Affordable Drugs applauded the ruling. “This decision marks the 10th court ruling in favor of patients and against the pharmaceutical industry’s desperate legal attacks on the overwhelmingly popular Medicare Negotiation Program, which in January will deliver lower prices to more than 9 million patients across the nation,” Merith Basey, the […]
News and Reports
Global Genes: ORPHAN Cures Act Removed from Senate Budget Reconciliation Bill
While industry groups and rare disease patient advocacy organizations, such as the Biotechnology Innovation Organization and National Organization for Rare Disorders, support passage of the ORPHAN Cures Act, other groups, such as Public Citizen, AARP, and Patients for Affordable Drugs Now, have opposed it. “This decision helps protect the popular and effective Medicare Drug Price […]
News and Reports
Fierce Pharma: In setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act
For its part, the Patients For Affordable Drugs Now (P4ADNOW), an organization focused on lowering drug prices, touted the exclusion of the Orphan Cures Act from the Senate’s reconciliation text as a “direct rejection of the pharmaceutical industry’s greed-driven agenda.” “This decision helps protect the popular and effective Medicare negotiation program and its promise of […]